EXPERIMENTAL IMMUNOLOGY
Confirmation of anti-DFS70 antibodies is needed in routine clinical samples with DFS staining pattern
Submission date: 2015-07-28
Final revision date: 2015-11-04
Acceptance date: 2016-02-23
Publication date: 2016-03-24
Cent Eur J Immunol 2016;41(1):6-11
KEYWORDS
ABSTRACT
Background: Recognition of nuclear dense fine speckled (DFS) pattern by indirect immunofluorescence (IIF) is not easy. Thus, confirming the presence of these antibodies might be needed. In this study, we aimed to determine the frequency of DFS pattern in our diagnostic laboratory and to investigate the presence of anti-DFS70 antibodies in samples showing DFS pattern by two commercially available research kits retrospectively.
Material and methods: Seventy-four sequential serum samples with DFS pattern on HEp2010 cell substrates by IIF were included in this study. The semiquantitative DFS70 ELISA Kit (MBL International Corporation, Woburn, UK) was used for detection of anti-DFS70 antibodies in these samples. Twenty selected samples were tested for the presence of anti-DFS70 antibodies using ANA Line Immunoassay (LIA) (Immco Diagnostics, New York, USA).
Results: Sixty-two (83.8%) of 74 serum samples were found positive with ELISA, when 15 U/ml was taken as a reference value. Among 18 samples that were found positive by ELISA, five were negative for anti-DFS70 antibodies by LIA, while 13 were found positive. The lowest ELISA result of the sample that was positive by LIA was found to be 45.3 U/ml. When 45.3 U/ml was considered as a reference value, 45 (60.8%) of 74 serum samples were positive by ELISA. Nineteen of 20 patients had no SARD, while one had systemic lupus erythematosus (SLE).
Conclusions: DFS pattern should be confirmed with an objective method such as ELISA, LIA, or IB. We think that confirmation tests for detection of anti-DFS70 antibodies should be included in diagnostic algorithms.
Material and methods: Seventy-four sequential serum samples with DFS pattern on HEp2010 cell substrates by IIF were included in this study. The semiquantitative DFS70 ELISA Kit (MBL International Corporation, Woburn, UK) was used for detection of anti-DFS70 antibodies in these samples. Twenty selected samples were tested for the presence of anti-DFS70 antibodies using ANA Line Immunoassay (LIA) (Immco Diagnostics, New York, USA).
Results: Sixty-two (83.8%) of 74 serum samples were found positive with ELISA, when 15 U/ml was taken as a reference value. Among 18 samples that were found positive by ELISA, five were negative for anti-DFS70 antibodies by LIA, while 13 were found positive. The lowest ELISA result of the sample that was positive by LIA was found to be 45.3 U/ml. When 45.3 U/ml was considered as a reference value, 45 (60.8%) of 74 serum samples were positive by ELISA. Nineteen of 20 patients had no SARD, while one had systemic lupus erythematosus (SLE).
Conclusions: DFS pattern should be confirmed with an objective method such as ELISA, LIA, or IB. We think that confirmation tests for detection of anti-DFS70 antibodies should be included in diagnostic algorithms.
REFERENCES (31)
1.
Meroni PL, Schur PH (2010): ANA screening: an old test with new recommendations. Ann Rheum Dis 69: 1420-1422.
2.
Fritzler MJ (2011): The antinuclear antibody test: last or lasting gasp? Arthritis Rheum 63: 19-22.
3.
Ochs RL, Muro Y, Si Y, et al. (2000): Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 105: 1211-1220.
4.
Ge H, Si Y, Roeder RG (1998): Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 17: 6723-6729.
5.
Shinohara T, Singh DP, Fatma N (2002): LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 21: 341-358.
6.
Ochs RL, Stein TW Jr., Peebles CL, et al. (1994): Autoantibodies in interstitial cystitis. J Urol 151: 587-592.
8.
Ganapathy V, Casiano CA (2004): Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis Rheum 50: 684-688.
9.
Okamoto M, Ogawa Y, Watanabe A, et al. (2004): Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun 23: 257-266.
10.
Ayaki M, Ohoguro N, Azuma N, et al. (2002): Detection of cytotoxic anti-LEDGF autoantibodies in atopic dermatitis. Autoimmunity 35: 319-327.
11.
Yamada K, Senju S, Shinohara T, et al. (2001): Humoral immune response directed against LEDGF in patients with VKH. Immunol Lett 78: 161-168.
12.
Mariz HA, Sato EI, Barbosa SH, et al. (2011): Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 63: 191-200.
13.
Miyara M, Albesa R, Charuel JL, et al. (2013): Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort. Clin Dev Immunol 2013: 703759.
14.
Muro Y, Sugiura K, Morita Y, Tomita Y (2008): High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus 17: 171-176.
15.
Watanabe A, Kodera M, Sugiura K, et al. (2004): Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 50: 892-900.
16.
Dellavance A, Viana VS, Leon EP, et al. (2005): The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. J Rheumatol 32: 2144-2149.
17.
Mahler M, Parker T, Peebles CL, et al. (2012): Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol 39: 2104-2110.
18.
Bizzaro N, Tonutti E, Villalta D (2011): Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEP-2 cells: not an easy task! Comment on the article by Mariz et al. Arthritis Rheum 63: 4036-4037.
19.
Mahler M, Hanly JG, Fritzler MJ (2012): Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev 11: 642-645.
20.
Mahler M, Fritzler MJ (2012): The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol 2012: 494356.
21.
Basu A, Woods-Burnham L, Ortiz G, et al. (2015): Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clin Immunol 161: 241-250.
22.
Bizzaro N, Tonutti E, Visentini D, et al. (2007): Antibodies to the lens and cornea in anti-DFS70-positive subjects. Ann N Y Acad Sci 1107: 174-183.
23.
Mahler M, Meroni PL, Bossuyt X, Fritzler MJ (2014): Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014: 315179.
24.
Almeida GD, Cabrera de LA, Rodriguez Perez MC, et al. (2010): Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. J Immunol Methods 360: 89-95.
25.
Sener AG, Afsar I, Demirci M (2014): Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods’: four years’ data from Turkey. APMIS 122: 1167-1170.
26.
Lee SA, Kahng J, Kim Y, et al. (2012): Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease. J Clin Lab Anal 26: 307-314.
27.
Fitch-Rogalsky C, Steber W, Mahler M, et al. (2014): Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies. PLoS One 9: e93812.
28.
Craig WY, Ledue TB (2011): The dense fine speckled antinuclear antibody pattern in autoimmune rheumatic disease: comment on the article by Mariz et al. Arthritis Rheum 63: 1759.
29.
Sheldon J, Dellavance A (2015): Strategies for building reference standards for autoantibodies. Front Immunol 6: 194.
30.
Berkun Y, Eisenstein EM (2014): Diagnostic criteria of familial Mediterranean fever. Autoimmun Rev 13: 388-390.
31.
Eisenstein EM, Berkun Y, Ben-Chetrit E (2013): Familial Mediterranean fever: a critical digest of the 2012-2013 literature. Clin Exp Rheumatol 31: 103-107.
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
